Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | CFTR | P13569 | 1/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.51 |
| ▸ | ACR | P10323 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL421226 | 0.83 | HSD17B10 (0.42) | SLC6A3TSHRLMNAL3MBTL1HSD17B10 | |
| Methyl 2-Methoxybenzoate SCHEMBL29702077 | 0.83 | TSHR (0.69) | SLC6A3TSHRLMNAL3MBTL1HSD17B10 | |
| SCHEMBL2441955 | 0.83 | SLC6A3 (0.65) | SLC6A3TSHRLMNAL3MBTL1HSD17B10 | |
| SCHEMBL1092308 | 0.83 | KDM4E (0.42) | SLC6A3TSHRLMNAL3MBTL1HSD17B10 | |
| Methyl 2-Methoxybenzoate SCHEMBL196037 | 0.83 | TSHR (0.69) | SLC6A3TSHRLMNAL3MBTL1HSD17B10 | |
| SCHEMBL28328627 | 0.82 | SLC6A3 (0.54) | SLC6A3TSHRLMNAL3MBTL1HSD17B10 | |
| Methyl 2-Methoxybenzoate SCHEMBL30744939 | 0.82 | MAPT (0.67) | SLC6A3TSHRLMNAL3MBTL1HSD17B10 | |
| SCHEMBL28432969 | 0.82 | KMT2A (0.63) | SLC6A3TSHRLMNAL3MBTL1HSD17B10 | |
| SCHEMBL28176283 | 0.82 | SLC6A3 (0.62) | SLC6A3TSHRLMNAL3MBTL1HSD17B10 | |
| SCHEMBL4199247 | 0.82 | SLC6A3 (0.62) | SLC6A3TSHRLMNAL3MBTL1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240167922-A1 | TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD | KYOTO UNIVERSITY (JP) | 2024-05-23 | — | — | US | disclosed |
| EP-4306927-A1 | TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD | Kyoto University (JP) | 2024-01-17 | — | — | EP | disclosed |
| WO-2022191336-A1 | TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD | 国立大学法人京都大学 | 2022-09-15 | — | — | WO | disclosed |
| CN-102119142-A | Salicylamide derivatives as nicotinic alpha 7 modulators | HOFFMANN LA ROCHE | 2011-07-06 | — | — | CN | disclosed |
| WO-2004032914-A2 | USE OF A PROPARGYL ALCOHOL ENANTIOMER FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2004-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240167922-A1 | TRANSPARENTIZING REAGENT AND TRANSPARENTIZING METHOD | TST, TTR, ALB | SLC6A3 4002/4885TSHR 2764/4885LMNA 1853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.